Position in NTLA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$4,551,100
-$9,668,900 QoQ
Shares Held
355,000
-82.2% QoQ
Ownership
0.254%
of shares outstanding
% of Portfolio
0.34%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2022
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NTLA Over Time
Shares Held
Position Value (USD)
Derivatives in NTLA
reported options exposure · as of Mar 31, 2024CallValue
$1,375,500
CallShares
50,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026Casdin Capital, LLC holds $705,487,766 across 26 Biotechnology names. NTLA ranks #15 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
2,577,333 | $250,645,634 | |
| 2 | RLAY |
Relay Therapeutics, Inc.
|
14,418,574 | $143,464,811 | |
| 3 | GPCR |
Structure Therapeutics Inc.
|
1,175,000 | $56,635,000 | |
| 4 | DNLI |
Denali Therapeutics Inc.
|
1,840,000 | $35,328,000 | |
| 5 | BEAM |
Beam Therapeutics Inc.
|
1,350,000 | $32,170,500 | |
| 6 | NGNE |
Neurogene Inc.
|
1,420,361 | $28,634,477 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
75,000 | $24,815,250 | |
| 8 | MAZE |
Maze Therapeutics, Inc.
|
758,857 | $22,651,881 |
All Filings in NTLA
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,551,100 | 355,000 | Shares | Sole | 2026-05-15 | |
| 2025-03-31 | $14,220,000 | 2,000,000 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $23,320,000 | 2,000,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $41,100,000 | 2,000,000 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $44,760,000 | 2,000,000 | Shares | Sole | 2024-10-18 | |
| 2024-03-31 | $1,375,500 | 50,000 | Call | Sole | 2024-05-15 | |
| 2024-03-31 | $51,581,250 | 1,875,000 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $44,210,500 | 1,450,000 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $37,250,731 | 1,178,075 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $51,994,500 | 1,275,000 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $47,519,250 | 1,275,000 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $10,292,550 | 295,000 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $16,508,200 | 295,000 | Shares | Sole | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||